Chemoinformaics analysis of 5-hydroxyaloin A
Molecular Weight | 434.397 | nRot | 3 |
Heavy Atom Molecular Weight | 412.221 | nRig | 22 |
Exact Molecular Weight | 434.121 | nRing | 4 |
Solubility: LogS | -3.922 | nHRing | 1 |
Solubility: LogP | 0.815 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
nHA | 10 | APOL | 57.7594 |
nHD | 8 | BPOL | 24.6746 |
QED | 0.197 |
Synth | 4.242 |
Natural Product Likeliness | 1.837 |
NR-PPAR-gamma | 0.489 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.173 |
HIA | 0.997 |
CACO-2 | -6.208 |
MDCK | 0.00000332 |
BBB | 0.015 |
PPB | 0.940479 |
VDSS | 0.766 |
FU | 0.124425 |
CYP1A2-inh | 0.356 |
CYP1A2-sub | 0.035 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.054 |
CYP2c9-inh | 0.017 |
CYP2c9-sub | 0.233 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.165 |
CYP3a4-inh | 0.025 |
CYP3a4-sub | 0.008 |
CL | 3.279 |
T12 | 0.821 |
hERG | 0.044 |
Ames | 0.782 |
ROA | 0.016 |
SkinSen | 0.936 |
Carcinogencity | 0.029 |
EI | 0.405 |
Respiratory | 0.038 |
NR-Aromatase | 0.038 |
Antiviral | Yes |
Prediction | 0.843729 |